Dr. Abbey Spoke About the VERONA Diabetic Macular Edema Clinical Trial at The Retina Society’s Annual Meeting
On behalf of the VERONA study investigators, Texas Retina’s Ashkan M. Abbey, MD, delivered a presentation titled “VERONA: End-of-Study Results from a Phase 2 Trial of EYP-1901 (vorolanib intravitreal insert) versus Aflibercept
read more
Dr. Abbey Presented 2.5 Year Results of the TRUCKEE Study at The Retina Society Annual Meeting
Texas Retina’s Ashkan M. Abbey, MD, presented “The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study – 2.5 Year Results” at the 57thAnnual Scientific Meeting of
read more
Dr. Abbey and Dr. Callanan Inducted into The Retina Society
Texas Retina’s Ashkan M. Abbey, MD, and retired Texas Retina physician David Callanan, MD, were officially inducted into The Retina Society at the organization’s 57th Annual Scientific Meeting held September 11-15, in
read more
Ashkan Abbey, MD, Presents at the 52nd Scientific Program of The Retina Society
Our physicians are passionate about saving sight through innovation. This past weekend, Texas Retina Associates’ Ashkan Abbey, MD, spoke at the 52nd Scientific Program of The Retina Society in London. The Retina
read more